Improvement in management of localized prostate cancer

After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone, according to a study.